Aortic regurgitation cardiac MRI: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Cardiac MRI may be used in the assessment of individuals with [[valvular heart disease]] among whom the evaluation of valvular stenosis, regurgitation, para- or perivalvular masses, perivalvular complications of infectious processes, or [[prosthetic valve]] disease is needed. Cardiovascular magnetic resonance (CMR) may be useful in | Cardiac MRI may be used in the assessment of individuals with [[valvular heart disease]] among whom the evaluation of valvular stenosis, regurgitation, para- or perivalvular masses, perivalvular complications of infectious processes, or [[prosthetic valve]] disease is needed. Cardiovascular magnetic resonance (CMR) may be useful in the identification of serial changes in [[left ventricular]] volume or mass among patients with valvular dysfunction. Among patients with suboptimal [[echocardiogram]]s, [[magnetic resonance imaging]] is used to to determine the severity of [[AR]] and assess [[left ventricular]] volume and function at rest. | ||
==2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Diseases (DO NOT EDIT)<ref>{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.full.pdf+html | publisher = | date = | accessdate = 4 March 2014 }}</ref>== | ==2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Diseases (DO NOT EDIT)<ref>{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.full.pdf+html | publisher = | date = | accessdate = 4 March 2014 }}</ref>== | ||
Revision as of 22:45, 6 January 2015
|
Aortic Regurgitation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Acute Aortic regurgitation |
|
Chronic Aortic regurgitation |
|
Special Scenarios |
|
Case Studies |
|
Aortic regurgitation cardiac MRI On the Web |
|
American Roentgen Ray Society Images of Aortic regurgitation cardiac MRI |
|
Risk calculators and risk factors for Aortic regurgitation cardiac MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cardiac MRI may be used in the assessment of individuals with valvular heart disease among whom the evaluation of valvular stenosis, regurgitation, para- or perivalvular masses, perivalvular complications of infectious processes, or prosthetic valve disease is needed. Cardiovascular magnetic resonance (CMR) may be useful in the identification of serial changes in left ventricular volume or mass among patients with valvular dysfunction. Among patients with suboptimal echocardiograms, magnetic resonance imaging is used to to determine the severity of AR and assess left ventricular volume and function at rest.
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Diseases (DO NOT EDIT)[1]
Diagnosis and Follow Up
| Class I |
| "1. CMR is indicated in patients with moderate or severe AR (stages B, C, and D) and suboptimal echocardiographic images for the assessment of LV systolic function, systolic and diastolic volumes, and measurement of AR severity. (Level of Evidence: B) " |
2010 ACCF/ACR/AHA/NASCI/SCMR Expert Consensus Document on Cardiovascular Magnetic Resonance (DO NOT EDIT)[2]
Cardiac MRI in Valvular Heart Disease (DO NOT EDIT)[2]
| “ |
CMR may be used for assessing individuals with valvular heart disease in which evaluation of valvular stenosis, regurgitation, para- or perivalvular masses, perivalvular complications of infectious processes, or prosthetic valve disease are needed. CMR may be useful in identifying serial changes in LV volumes or mass in patients with valvular dysfunction. |
” |
2008 Focused Update Incorporated Into the 2006 ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease (DO NOT EDIT)[3]
Cardiac MRI (DO NOT EDIT)[3]
| Class I |
| "1. Radionuclide angiography or magnetic resonance imaging is indicated for the initial and serial assessment of LV volume and function at rest in patients with AR and suboptimal echocardiograms. (Level of Evidence: B)" |
| Class IIa |
| "1. Magnetic resonance imaging is reasonable for the estimation of AR severity in patients with unsatisfactory echocardiograms. (Level of Evidence: B)" |
Sources
- 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease[3]
- 2010 ACCF/ACR/AHA/NASCI/SCMR expert consensus document on cardiovascular magnetic resonance[2]
References
- ↑ "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.
- ↑ 2.0 2.1 2.2 American College of Cardiology Foundation Task Force on Expert Consensus Documents. Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA; et al. (2010). "ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents". Circulation. 121 (22): 2462–508. doi:10.1161/CIR.0b013e3181d44a8f. PMC 3034132. PMID 20479157.
- ↑ 3.0 3.1 3.2 Bonow RO, Carabello BA, Chatterjee K; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Unknown parameter
|month=ignored (help)